Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy

Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy

Background: The benefit of aspirin in rectal cancer during chemoradiation therapy (CRT) and the factors affecting its efficacy are not well characterized. We compared the outcomes of rectal patients undergoing neoadjuvant CRT based on aspirin use. Methods: Patients undergoing CRT for rectal cancer f...

Full description

Bibliographic Details
Main Authors: Mark K. Farrugia, Mark D. Long, David M. Mattson, Leayn T. Flaherty, Bowen Dong, Eduardo Cortes Gomez, Lei Wei, Agnieszka K. Witkiewicz, Song Yao, Pawel Kalinski, Anurag K. Singh
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
rectal cancer
chemoradiation
aspirin
tumor response
survival
Online Access:https://www.mdpi.com/2072-6694/13/2/205

Internet

https://www.mdpi.com/2072-6694/13/2/205

Similar Items